Search Results for: "janssen v. celltrion"

FDA Approvals

To view our full FDA Approvals tracking table, click here. Adalimumab+ HUMIRA #1 Biosimilar: AMJEVITA (adalimumab-atto) Applicant: Amgen BLA Approval: Sept. 23, 2016 US Launch: January…

Read More